RNS Number : 8788S
Immupharma PLC
28 June 2018
 

 

 

 

                                                                                                                       28 JUNE 2018

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

 

2018 ANNUAL GENERAL MEETING - ALL RESOLUTIONS PASSED

 

 

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.

-Ends-

 

 

For further information please contact:

 

ImmuPharma PLC (www.immupharma.co.uk)

+ 44 (0) 20 7152 4080

Tim McCarthy, Chairman

 

Lisa Baderoon, Head of Investor Relations

Twitter: @immupharma

 

+ 44 (0) 7721 413496

 

 

 

 

Northland Capital Partners Limited (NOMAD & Joint Broker)

David Hignell, Dugald Carlean, Jamie Spotswood, Corporate Finance

Rob Rees, Corporate Broking

 

 

+44 (0)20 3861 6625

 

 

 

 

Bryan, Garnier & Co. (Joint Broker)

Phil Walker, Corporate Finance

Dominic Wilson, Sales

+44 (0)20 7332 2500

 

 

                                                                    

 

 

 
     

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGFMGZVNRLGRZG ]]>